NCT00158080

Brief Summary

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
Last Updated

September 12, 2005

Status Verified

September 1, 2005

First QC Date

September 7, 2005

Last Update Submit

September 7, 2005

Conditions

Chronic Kidney DiseaseCardiac Catheterization

Outcome Measures

Primary Outcomes (1)

  • Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcomes (1)

  • Need for hemodialysis

Interventions

hemofiltrationPROCEDURE

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with serum creatinine\>2.0mg/dl and/or GFR\<50ml/min

You may not qualify if:

  • Emergent cardiac catheterization
  • Patients on chronic dialysis
  • Patients with HYHA\>III heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Dept of InternalMedicine, Nara Medical University

Kashihara, Nara, 634-8522, Japan

RECRUITING

Related Publications (1)

  • Kashyap AS, Anand KP, Kashyap S. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med. 2004 Feb 19;350(8):836-8; author reply 836-8. No abstract available.

    PMID: 14978842BACKGROUND

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Hemofiltration

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Renal Replacement TherapyTherapeuticsExtracorporeal CirculationSurgical Procedures, Operative

Study Officials

  • Yoshihiko Saito, MD, PhD

    Nara Medical University

    STUDY DIRECTOR

Central Study Contacts

Koji Harada, MD

CONTACT

+81-744-22-3051kzharada@naramed-u.ac.jp

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 7, 2005

First Posted

September 12, 2005

Last Updated

September 12, 2005

Record last verified: 2005-09

Locations

JP(1)